185 related articles for article (PubMed ID: 16304877)
1. Use of recombinant factor VIIa for massive postpartum haemhorrage: case series and review of literature.
Shamsi TS; Hossain N; Soomro N; Hasan JA; Noorani M; Kazi S; Quraishy MS; Jameel B; Sultan ST; Haider S
J Pak Med Assoc; 2005 Nov; 55(11):512-5. PubMed ID: 16304877
[TBL] [Abstract][Full Text] [Related]
2. [Glanzmann thrombasthenia and pregnancy--report of a case and literature review].
Uchikova E; Pechlivanov B; Parahuleva N; Amaliev G
Akush Ginekol (Sofiia); 2014; 53(5):49-51. PubMed ID: 25558673
[TBL] [Abstract][Full Text] [Related]
3. [Effect of recombinant activated factor VII (RFVIIA; NovoSeven) in a patient in haemorrhagic shock after obstetrical hysterectomy].
Sobieszczyk S; Breborowicz GH; Markwitz W; Mallinger S; Adamski D; Kruszyński Z
Ginekol Pol; 2002 Mar; 73(3):230-3. PubMed ID: 12092258
[TBL] [Abstract][Full Text] [Related]
4. The role of recombinant activated Factor VII in major obstetric haemorrhage: the Farnborough experience.
Wissa I; Ebeid E; El-Shawarby S; Chandakas S; Kamal T; Hill N
J Obstet Gynaecol; 2009 Jan; 29(1):21-4. PubMed ID: 19280490
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of recombinant activated factor VII (rFVII a) for controlling intractable postpartum bleeding: report of two cases and literature review.
Jirapinyo M; Manonai J; Herabutya Y; Chuncharunee S
J Med Assoc Thai; 2007 May; 90(5):977-81. PubMed ID: 17596055
[TBL] [Abstract][Full Text] [Related]
6. [The use of recombinant factor VIIa on the therapy of massive bleeding after cesarean section].
Uharcek P; Mlyncek M; Kellner M; Lajtman E
Ceska Gynekol; 2007 May; 72(3):200-2. PubMed ID: 17616074
[TBL] [Abstract][Full Text] [Related]
7. Treatment of obstetric hemorrhage with recombinant activated factor VII (rFVIIa).
Segal S; Shemesh IY; Blumenthal R; Yoffe B; Laufer N; Ezra Y; Levy I; Mazor M; Martinowitz U
Arch Gynecol Obstet; 2003 Oct; 268(4):266-7. PubMed ID: 14504866
[TBL] [Abstract][Full Text] [Related]
8. Recombinant activated factor VII in obstetric hemorrhage: experiences from the Australian and New Zealand Haemostasis Registry.
Phillips LE; McLintock C; Pollock W; Gatt S; Popham P; Jankelowitz G; Ogle R; Cameron PA;
Anesth Analg; 2009 Dec; 109(6):1908-15. PubMed ID: 19923520
[TBL] [Abstract][Full Text] [Related]
9. Caesarean section for placenta praevia complicated by postpartum haemorrhage managed successfully with recombinant activated human coagulation Factor VIIa.
Gidiri M; Noble W; Rafique Z; Patil K; Lindow SW
J Obstet Gynaecol; 2004 Nov; 24(8):925-6. PubMed ID: 16147656
[No Abstract] [Full Text] [Related]
10. Use of recombinant activated factor VII in a case of severe postpartum haemorrhage.
Verre M; Bossio F; Mammone A; Piccirillo M; Tancioni F; Varano M
Minerva Ginecol; 2006 Feb; 58(1):81-4. PubMed ID: 16498374
[TBL] [Abstract][Full Text] [Related]
11. Guidelines for the use of recombinant activated factor VII in massive obstetric haemorrhage.
Welsh A; McLintock C; Gatt S; Somerset D; Popham P; Ogle R
Aust N Z J Obstet Gynaecol; 2008 Feb; 48(1):12-6. PubMed ID: 18275566
[TBL] [Abstract][Full Text] [Related]
12. Massive postpartum hemorrhage: recombinant factor VIIa use is safe but not effective.
Kalina M; Tinkoff G; Fulda G
Del Med J; 2011 Apr; 83(4):109-13. PubMed ID: 21675158
[TBL] [Abstract][Full Text] [Related]
13. Successful management by recombinant activated factor VII in a case of disseminated intravascular coagulopathy caused by obstetric hemorrhage.
Nohira T; Osakabe Y; Suda S; Takahashi C; Tanaka A; Ikeda K; Ikeda T; Okabe K
J Obstet Gynaecol Res; 2008 Aug; 34(4 Pt 2):623-30. PubMed ID: 18840167
[TBL] [Abstract][Full Text] [Related]
14. A critical review on the use of recombinant factor VIIa in life-threatening obstetric postpartum hemorrhage.
Franchini M; Franchi M; Bergamini V; Salvagno GL; Montagnana M; Lippi G
Semin Thromb Hemost; 2008 Feb; 34(1):104-12. PubMed ID: 18393147
[TBL] [Abstract][Full Text] [Related]
15. [Postpartum hemorrhage successfully treated with recombinant factor VIIa in Glanzmann thromboasthenia].
Sugihara S; Katsutani S; Hyodo H; Hyodo M; Kudo Y; Fujii T; Kimura A
Rinsho Ketsueki; 2008 Jan; 49(1):46-50. PubMed ID: 18277596
[TBL] [Abstract][Full Text] [Related]
16. [Our experince with the use of recombinant activated factor VII in postpartum haemorrhage].
Mostić T; Sparić R; Argirović R; Ljubić A; Bozanović T; Arsenijević L; Tomanović-Koković J; Stefanović A
Srp Arh Celok Lek; 2008 Sep; 136 Suppl 3():204-9. PubMed ID: 19562869
[TBL] [Abstract][Full Text] [Related]
17. Use of recombinant factor VIIa in massive post-partum haemorrhage.
McMorrow RC; Ryan SM; Blunnie WP; Bowen M; Carton EG; Gardiner J; Geary M; Loughrey JP
Eur J Anaesthesiol; 2008 Apr; 25(4):293-8. PubMed ID: 18177539
[TBL] [Abstract][Full Text] [Related]
18. [Post-partum hemorrhage: new therapeutic options].
Franchini M
Recenti Prog Med; 2007 Jan; 98(1):7-11. PubMed ID: 17345873
[TBL] [Abstract][Full Text] [Related]
19. [Acquired haemophilia A presenting in postpartum period--case report].
Mitrović-Vasiljević M; Antić D; Elezović I; Bila J; Todorović M
Srp Arh Celok Lek; 2008 Sep; 136 Suppl 3():214-7. PubMed ID: 19562871
[TBL] [Abstract][Full Text] [Related]
20. [Using recombinant activated coagulation factor VII (NovoSeven) in obstetrics].
Pekhlivanov B; Milchev N; Abrashev B
Akush Ginekol (Sofiia); 2003; 42(6):7-9. PubMed ID: 15067806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
